Rivaroxaban
- CAS number
- 366789-02-8
- Application
- Rivaroxaban is an orally active, direct inhibitor of Factor Xa, a crucial component of the intrinsic and extrinsic pathways of the blood coagulation cascade.
- Molecular weight
- 435.88 g/mol
- Molecular formula
- C19H18ClN3O5S
- Routes
- Oral
SOCOSUR PDE monographs are a quick and efficient way to obtain:
- Risks identification
- Identification of potential critical effects
- Rationale for NOAEL values selection
- Complete description of adjustment factors F1 to F5 as well as PK correction
- Complete review of all relevant pharmaceutical and medical databases, public or private, European or not in accordance with EMA guideline EMA/CHMP/CVMP/SWP/169430/2012, signed by an European toxicological expert with full CV
Benefits of such PDE monograph
A 16 to 25 pages report optimized in case of Regulatory Body inspection with all calculation details and all bibliographic references linked to these calculations.
How to initiate a quotation request and a supplier qualification within your quality system?
